Allergic Contact Dermatitis
📧 Sign up to get email alerts when something new happens for Allergic Contact Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-12-14FDA Approved: HYDROCORTISONE VALERATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's hydrocortisone valerate as a generic topical corticosteroid under an original ANDA (ANDA211750).
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Immune Reactions in Contact Dermatitis Affected Skin
A completed clinical trial examining immune reactions in skin affected by allergic contact dermatitis.
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: Low Dose Exposure to Oxidized R-limonene - A Repeated Open Application Test (ROAT) Study [NA]
This clinical trial update reports on low-dose exposure to oxidized R-limonene using a repeated open application test (ROAT) for allergic co…
-
FDA approval · 2018-03-26FDA Approved: CLOBETASOL PROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a generic clobetasol propionate topical product from Glenmark Pharmaceuticals (ANDA 209004) for treatment of inflammatory and p…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy [NA]
This completed clinical trial evaluated the importance of information provided to patients with allergic contact dermatitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-01-09Clinical Trial Update: Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity [NA]
A clinical trial update describing safety dermatological assessments of a topical dressings product to evaluate photoirritation and dermal p…
-
CLINICAL_TRIALS research · 2016-09-26Clinical Trial Update: Epidemiology and Co-Reactivity of Novel Surfactant Allergens [NA]
A completed clinical investigation examining the epidemiology and cross-reactivity of novel surfactant allergens in allergic contact dermati…
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Anti-IL-17 a New Treatment for Contact Dermatititis [Phase 3]
A Phase 3 clinical trial update evaluating an anti-IL-17A agent for allergic contact dermatitis.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Assess Itch Behavior in Nickel Sulphate Sensitized Volunteers [Phase 1]
Phase 1 clinical trial update assessing itch behavior in nickel sulfate-sensitized volunteers with allergic contact dermatitis; the study st…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis [Phase 1, Phase 2]
This clinical trial update reports safety, tolerability, and preliminary efficacy data for 21 days of dermal MRX-6 in mild to moderate aller…
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis [Phase 4]
Phase 4 study evaluating tacrolimus ointment for chronic allergic contact dermatitis has completed and reports safety and efficacy findings.
-
FDA label_change · 2014-04-02FDA Approved: HALOG — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA supplemental application for HALOG (halcinonide cream) submitted by Sun Pharmaceutical Industries, Inc., with the submission status indi…
-
FDA approval · 2013-08-09FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a generic topical fluocinonide acetonide product under an original application from Padagis Israel Pharmaceuticals Ltd.
-
CLINICAL_TRIALS research · 2013-03-22Clinical Trial Update: Evaluation of Irritancy/Allergic Sensitivity to Natural Personal-care Products by Patch Tests [NA]
Clinical trial evaluating irritancy and allergic sensitivity to natural personal-care products via patch tests; current status is unknown.
-
FDA approval · 2012-01-03FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Desoximetasone from Sun Pharmaceutical Industries, Inc., resulting in changes to the product lab…
-
CLINICAL_TRIALS research · 2011-08-10Clinical Trial Update: Nickel Desensitization Using Topical Therapy [NA]
An update on a nickel desensitization approach using topical therapy for allergic contact dermatitis; the current trial status is unknown.
-
FDA approval · 2011-07-26FDA Approved: ALCLOMETASONE DIPROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for aclometasone dipropionate from Sun Pharmaceutical Industries, Inc. The approval confirms the cha…
-
CLINICAL_TRIALS trial_result · 2010-12-20Clinical Trial Update: Study of Apremilast in Atopic or Contact Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating apremilast for atopic dermatitis and allergic contact dermatitis was completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: NI-0801 in Allergic Contact Dermatitis [Phase 1]
NI-0801 has completed a Phase 1 clinical trial for allergic contact dermatitis, according to the clinical trial update.
-
FDA approval · 2007-11-28FDA Approved: HYDROCORTISONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Hydrocortisone by Padagis Israel Pharmaceuticals Ltd, indicating an update to the product's appr…
-
CLINICAL_TRIALS research · 2007-10-04Clinical Trial Update: Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine (PPD). Analysis of Cellular and Molecular Targets in Skin Inflammation
The study investigates the cellular and molecular mechanisms underlying allergic contact dermatitis triggered by para-phenylenediamine (PPD)…
-
CLINICAL_TRIALS trial_result · 2006-07-25Clinical Trial Update: CP-481,715 Nickel Allergy Study. [Phase 1]
Pfizer's Phase 1 trial of CP-481,715 for allergic contact dermatitis (nickel allergy) has completed.